Most "adaptogen" marketing runs ahead of the evidence. Ashwagandha is one of the few exceptions -- it has a genuine cluster of placebo-controlled human trials measuring an objective biomarker (serum cortisol) rather than relying entirely on self-report. That does not mean every claim made about it holds up, but the core stress-axis effect is unusually well documented for a botanical supplement.
This guide covers the HPA-axis mechanism, the cortisol and stress trial data, the more contested testosterone question, dosing, and which extract to actually buy.
What Ashwagandha Does — The HPA-Axis Mechanism
Withania somnifera is a nightshade-family root used for centuries in Ayurvedic medicine, but the modern evidence base rests on standardized root extracts -- not the raw powdered herb -- concentrated for withanolides, the steroidal lactone compounds believed to drive its effects.
The mechanistic story runs through the hypothalamic-pituitary-adrenal (HPA) axis, the same stress-response system that governs cortisol release under chronic psychological or physiological stress. Animal and cell research suggests withanolides modulate GABA-A receptor signaling and blunt the HPA-axis's cortisol output in response to stressors, without appearing to suppress baseline cortisol needed for normal function. This distinguishes it mechanistically from a sedative -- the claim is stress-axis regulation, not sedation.
| Feature | Ashwagandha (KSM-66) | Rhodiola / other adaptogens |
|---|---|---|
| Primary mechanism | HPA-axis modulation, blunts stress-induced cortisol release | Varies widely by botanical, less consistent mechanism data |
| Key human RCT | Chandrasekhar 2012: 300mg BID, 60 days, −27.9% cortisol | Mostly smaller or unreplicated trials |
| Testosterone effect | Positive in 2 specific populations (Wankhede 2015, Lopresti 2019) | No consistent evidence for most adaptogens |
| Typical effective dose | 600mg/day (300mg twice daily) | Varies, often less standardized |
| Cost per month | ~$12–20 | ~$15–30 |
| Best paired with | Magnesium glycinate, sleep optimization protocol | Varies |
The Cortisol and Stress Evidence
The strongest single trial in the ashwagandha literature is Chandrasekhar, Kapoor, and Anishetty (2012, Indian Journal of Psychological Medicine). This was a prospective, randomized, double-blind, placebo-controlled study in adults with self-reported chronic stress, using a high-concentration, full-spectrum root extract at 300mg twice daily for 60 days.
Lopresti et al. (2019, Medicine) ran a similarly designed randomized, double-blind, placebo-controlled trial using a comparable extract and dosing window, and again found significant reductions in serum cortisol along with improvements on stress and anxiety instruments. Salve et al. (2019, Cureus) used a high-concentration full-spectrum root extract and found improvements in both perceived stress scores and self-reported sleep quality over an 8-week period.
The Testosterone Question
This is the more contested part of the ashwagandha story, and it is worth being precise about which populations the positive data actually applies to.
Wankhede 2015 — Resistance-Trained Men
Lopresti 2019 — Aging, Overweight Men
Lopresti, Drummond, and Smith (2019, American Journal of Men's Health) ran a randomized, double-blind, placebo-controlled crossover study specifically in aging, overweight males with borderline-low testosterone. Ashwagandha supplementation was associated with statistically significant increases in serum testosterone and DHEA-S relative to placebo, alongside improvements on self-reported vitality and well-being scales.
What the evidence does not show is a testosterone effect in healthy young men with already-normal testosterone levels, or that ashwagandha functions as a substitute for testosterone replacement therapy in men with diagnosed hypogonadism. The signal is specific to populations with elevated stress-driven cortisol (which independently suppresses testosterone via HPA-axis crosstalk) or age-related decline -- consistent with a stress-axis mechanism rather than a direct androgenic one.
Dosage and Which Extract to Buy
The most-replicated protocol across the Chandrasekhar, Wankhede, and Lopresti trials is 600mg/day of a high-concentration, full-spectrum root extract, most often split as 300mg twice daily, taken for a minimum of 8 weeks before assessing effect. Raw ashwagandha powder in traditional Ayurvedic dosing is not the same product tested in these RCTs and carries much less predictable withanolide content.
KSM-66 vs. Sensoril
KSM-66 is a trademarked, full-spectrum root-only extract (Ixoreal Biomed) and is the specific extract used in Chandrasekhar 2012 and several related trials. Sensoril is a different trademarked extract (root and leaf) with a higher concentrated withanolide glycoside content, used in some of the earlier stress and sleep trials. Both have trial-backed data; products that name one of these two extracts specifically carry more confidence than generic "ashwagandha extract" labeling with no standardization disclosed.
Timing: Most trial protocols dosed twice daily (morning and evening) with food. Because ashwagandha's most consistent secondary effect is improved sleep quality, some users prefer to concentrate more of the daily dose in the evening.
Onset: The cortisol and stress trials measured outcomes at 8 and 60 days -- this is not a same-day anxiolytic. Give it the same 8-week minimum trial window used in the research before judging whether it is working.
Who Should Consider Ashwagandha
- Adults with chronic, non-clinical stress who want an intervention with actual cortisol biomarker data rather than a purely subjective "calm" supplement.
- Aging or overweight men with borderline-low testosterone and elevated perceived stress, where the Lopresti 2019 population most closely matches.
- Resistance-trained individuals looking for a recovery and strength-training adjunct with the Wankhede 2015 data behind it.
- Those with stress-related sleep disruption not explained by a separate diagnosed sleep disorder.
Safety
Ashwagandha has a generally favorable safety profile at studied doses, but it has been shown in some trials to modestly increase thyroid hormone (T3/T4) output, which matters for people with hyperthyroidism specifically. Rare case reports of liver injury exist in the pharmacovigilance literature, generally associated with unverified extracts or doses well above the studied range. As with any supplement carrying this kind of signal, sticking to a standardized extract (KSM-66 or Sensoril) at the studied 600mg/day dose, and discussing use with a physician if thyroid disease, pregnancy, or autoimmune conditions are present, is the conservative approach.
Verdict
Evidence-Based Verdict
Related Reading
Ashwagandha's stress-axis effects intersect with several other longevity levers on this site. For the testosterone side of the equation, see our guide to testosterone decline and natural optimization and our breakdown of DHEA and adrenal aging. For the chronic stress mechanism itself, read our guide to cortisol, chronic stress, and telomere aging. If sleep disruption is your primary complaint, our sleep optimization guide covers the mechanisms in more depth, and our HRV and vagal tone guide covers how to actually measure your stress resilience over time.